NASDAQ:ANGO - AngioDynamics Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $15.38 +0.17 (+1.12 %) (As of 12/6/2019 10:36 AM ET) Add Compare Today's Range$15.24Now: $15.38▼$15.4150-Day Range$14.09MA: $15.07▼$15.6552-Week Range$13.72Now: $15.38▼$25.48Volume37,737 shsAverage Volume234,649 shsMarket Capitalization$578.60 millionP/E Ratio18.53Dividend YieldN/ABeta0.62 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:ANGO Previous Symbol CUSIP03475V10 CIK1275187 Webhttp://www.angiodynamics.com/ Phone518-795-1400Debt Debt-to-Equity RatioN/A Current Ratio3.53 Quick Ratio2.57Price-To-Earnings Trailing P/E Ratio18.53 Forward P/E Ratio128.17 P/E GrowthN/A Sales & Book Value Annual Sales$359.48 million Price / Sales1.61 Cash Flow$1.54 per share Price / Cash Flow9.96 Book Value$16.52 per share Price / Book0.93Profitability EPS (Most Recent Fiscal Year)$0.83 Net Income$61.34 million Net Margins17.79% Return on Equity4.89% Return on Assets3.69%Miscellaneous Employees1,050 Outstanding Shares37,620,000Market Cap$578.60 million Next Earnings Date1/3/2020 (Estimated) OptionableOptionable Receive ANGO News and Ratings via Email Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:ANGO Rates by TradingView AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions What is AngioDynamics' stock symbol? AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO." How were AngioDynamics' earnings last quarter? AngioDynamics, Inc. (NASDAQ:ANGO) announced its quarterly earnings data on Thursday, October, 3rd. The medical instruments supplier reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.04. The medical instruments supplier earned $66 million during the quarter, compared to analyst estimates of $67.74 million. AngioDynamics had a net margin of 17.79% and a return on equity of 4.89%. The firm's revenue for the quarter was up 3.3% on a year-over-year basis. During the same quarter last year, the business posted $0.16 EPS. View AngioDynamics' Earnings History. When is AngioDynamics' next earnings date? AngioDynamics is scheduled to release their next quarterly earnings announcement on Friday, January 3rd 2020. View Earnings Estimates for AngioDynamics. What guidance has AngioDynamics issued on next quarter's earnings? AngioDynamics updated its FY20 earnings guidance on Thursday, October, 3rd. The company provided EPS guidance of $0.10-0.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.26. The company issued revenue guidance of $280-286 million, compared to the consensus revenue estimate of $281.89 million. What price target have analysts set for ANGO? 2 brokerages have issued 12-month price objectives for AngioDynamics' stock. Their forecasts range from $21.00 to $23.00. On average, they expect AngioDynamics' stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 43.0% from the stock's current price. View Analyst Price Targets for AngioDynamics. What is the consensus analysts' recommendation for AngioDynamics? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AngioDynamics. Has AngioDynamics been receiving favorable news coverage? News articles about ANGO stock have been trending somewhat positive recently, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. AngioDynamics earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for AngioDynamics. Are investors shorting AngioDynamics? AngioDynamics saw a decline in short interest in the month of November. As of November 15th, there was short interest totalling 748,500 shares, a decline of 7.9% from the October 31st total of 812,500 shares. Based on an average daily trading volume, of 267,200 shares, the days-to-cover ratio is currently 2.8 days. Approximately 2.0% of the shares of the company are sold short. View AngioDynamics' Current Options Chain. Who are some of AngioDynamics' key competitors? Some companies that are related to AngioDynamics include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Varian Medical Systems (VAR). What other stocks do shareholders of AngioDynamics own? Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include Oasis Petroleum (OAS), Intel (INTC), General Electric (GE), FireEye (FEYE), Mattel (MAT), Hanesbrands (HBI), Marathon Oil (MRO), Bank of America (BAC), Chesapeake Energy (CHK) and Centurylink (CTL). Who are AngioDynamics' key executives? AngioDynamics' management team includes the folowing people: Mr. James C. Clemmer, CEO, Pres & Director (Age 55)Mr. Michael C. Greiner, Exec. VP & CFO (Age 46)Mr. David D. Helsel, Sr. VP of Global Operations and R&D (Age 55)Mr. Stephen A. Trowbridge, Sr. VP & Gen. Counsel (Age 45)Mr. Robert A. Simpson, Sr. VP & GM of Vascular Interventions and Therapies (Age 47) Who are AngioDynamics' major shareholders? AngioDynamics' stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (3.69%), Tributary Capital Management LLC (1.80%), Fenimore Asset Management Inc. (1.52%), Granahan Investment Management Inc. MA (1.11%), Systematic Financial Management LP (1.09%) and Foundry Partners LLC (0.65%). Company insiders that own AngioDynamics stock include James C Clemmer, Kevin J Gould and Michael Greiner. View Institutional Ownership Trends for AngioDynamics. Which institutional investors are selling AngioDynamics stock? ANGO stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Squarepoint Ops LLC, Man Group plc, Tributary Capital Management LLC, Barclays PLC, Foundry Partners LLC, State Street Corp and Keybank National Association OH. View Insider Buying and Selling for AngioDynamics. Which institutional investors are buying AngioDynamics stock? ANGO stock was acquired by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Mackay Shields LLC, Assenagon Asset Management S.A., Boston Advisors LLC, Systematic Financial Management LP, Granahan Investment Management Inc. MA, Tibra Equities Europe Ltd and Meeder Asset Management Inc.. View Insider Buying and Selling for AngioDynamics. How do I buy shares of AngioDynamics? Shares of ANGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is AngioDynamics' stock price today? One share of ANGO stock can currently be purchased for approximately $15.38. How big of a company is AngioDynamics? AngioDynamics has a market capitalization of $578.60 million and generates $359.48 million in revenue each year. The medical instruments supplier earns $61.34 million in net income (profit) each year or $0.83 on an earnings per share basis. AngioDynamics employs 1,050 workers across the globe.View Additional Information About AngioDynamics. What is AngioDynamics' official website? The official website for AngioDynamics is http://www.angiodynamics.com/. How can I contact AngioDynamics? AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected] MarketBeat Community Rating for AngioDynamics (NASDAQ ANGO)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 317 (Vote Outperform)Underperform Votes: 390 (Vote Underperform)Total Votes: 707MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe ANGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANGO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/6/2019 by MarketBeat.com StaffFeatured Article: Federal Reserve